Susanne Kreutz

Global Head, Business Development & Licensing Oncology

Novartis Pharma AG, Basel (CH)

Susanne Kreutz is the Global Head of Business Development & Licensing for Oncology at Novartis Pharma AG since October 2019 and is a member of the Novartis Oncology Leadership Team.

Before joining Novartis, Susanne served as the Vice President M&A Pharma at Bayer AG. She has a deep and broad experience in BD&L, having held various global and regional BD&L leadership positions across different therapeutic areas for early and late stage partnering at Bayer. As  Director   & Head of US Pharma BD&L at Bayer, she was responsible for building and leading the new BD&L function across all pharma business units. She also supported a global product (Xofigo) launch during her time as the Deputy Director Global Strategic Marketing for Oncology.

Susanne is a pharmacist by training and holds a PhD in Neuroscience from the University of Frankfurt.